Table II.
Correlation between PCED1B-AS1 expression levels and the clinicopathologic characteristics of the 47 patients with PDAC.
| PCED1B-AS1 expression | ||||
|---|---|---|---|---|
| Clinicopathological characteristic | n | High, n=25 | Low, n=22 | P-value |
| Age, years | 0.282 | |||
| ≥60 | 21 | 13 | 8 | |
| <60 | 26 | 12 | 14 | |
| Sex | 0.106 | |||
| Male | 22 | 15 | 8 | |
| Female | 25 | 10 | 14 | |
| Tumor size, cm | 0.119 | |||
| >2 | 27 | 17 | 10 | |
| ≤2 | 20 | 8 | 12 | |
| Differentiation | 0.191 | |||
| Poor | 24 | 15 | 9 | |
| Moderate and well | 23 | 10 | 13 | |
| Tumor-Node-Metastasis stage | 0.028a | |||
| I+II | 14 | 4 | 10 | |
| III+IV | 33 | 21 | 12 | |
| Distant metastasis | 0.118 | |||
| Negative | 33 | 20 | 13 | |
| Positive | 14 | 5 | 9 | |
| Lymph node metastasis | 0.0141a | |||
| Absent | 21 | 7 | 14 | |
| Present | 26 | 18 | 8 | |
a
P<0.05. PDAC, pancreatic ductal adenocarcinoma; PCED1B-AS1, PC-esterase domain containing 1B-antisense RNA 1.